Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control

View ORCID ProfileAidan M. Tousley, View ORCID ProfileMaria Caterina Rotiroti, View ORCID ProfileLouai Labanieh, Lea Wenting Rysavy, Skyler P. Rietberg, View ORCID ProfileEva L. de la Serna, View ORCID ProfileGuillermo Nicolas Dalton, View ORCID ProfileDorota Klysz, View ORCID ProfileEvan W. Weber, View ORCID ProfileWon-Ju Kim, Peng Xu, View ORCID ProfileElena Sotillo, View ORCID ProfileAlexander R. Dunn, View ORCID ProfileCrystal L. Mackall, View ORCID ProfileRobbie G. Majzner
doi: https://doi.org/10.1101/2022.06.17.496457
Aidan M. Tousley
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aidan M. Tousley
Maria Caterina Rotiroti
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Caterina Rotiroti
Louai Labanieh
2Department of Bioengineering, Stanford University, Stanford, California
3Parker Institute for Cancer Immunotherapy, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louai Labanieh
Lea Wenting Rysavy
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Skyler P. Rietberg
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva L. de la Serna
5Department of Chemical Engineering, Stanford University, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eva L. de la Serna
Guillermo Nicolas Dalton
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guillermo Nicolas Dalton
Dorota Klysz
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dorota Klysz
Evan W. Weber
3Parker Institute for Cancer Immunotherapy, San Francisco, California
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evan W. Weber
Won-Ju Kim
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Won-Ju Kim
Peng Xu
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Sotillo
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elena Sotillo
Alexander R. Dunn
5Department of Chemical Engineering, Stanford University, Stanford, California
7Stanford Cardiovascular Institute, Stanford School of Medicine, Stanford, California
8Biophysics Program, Stanford University, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander R. Dunn
Crystal L. Mackall
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
3Parker Institute for Cancer Immunotherapy, San Francisco, California
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
9Department of Medicine, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Crystal L. Mackall
Robbie G. Majzner
1Department of Pediatrics, Stanford University School of Medicine, Stanford, California
3Parker Institute for Cancer Immunotherapy, San Francisco, California
4Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robbie G. Majzner
  • For correspondence: rmajzner@stanford.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

While CAR T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumor toxicity has hampered their development for solid tumors because most target antigens are shared with normal cells. Researchers have attempted to apply Boolean logic gating to CAR T cells to prevent on-target, off-tumor toxicity; however, a truly safe and effective logic-gated CAR has remained elusive. Here, we describe a novel approach to CAR engineering in which we replace traditional ITAM-containing CD3ζ domains with intracellular proximal T cell signaling molecules. We demonstrate that certain proximal signaling CARs, such as a ZAP-70 CAR, can activate T cells and eradicate tumors in vivo while bypassing upstream signaling proteins such as CD3ζ. The primary role of ZAP-70 is to phosphorylate LAT and SLP-76, which form a scaffold for the propagation of T cell signaling. We leveraged the cooperative role of LAT and SLP-76 to engineer Logic-gated Intracellular NetworK (LINK) CAR, a rapid and reversible Boolean-logic AND-gated CAR T cell platform that outperforms other systems in both efficacy and the prevention of on-target, off-tumor toxicity. LINK CAR will dramatically expand the number and types of molecules that can be targeted with CAR T cells, enabling the deployment of these powerful therapeutics for solid tumors and diverse diseases such as autoimmunity and fibrosis. In addition, this work demonstrates that the internal signaling machinery of cells can be repurposed into surface receptors, a finding that could have broad implications for new avenues of cellular engineering.

Competing Interest Statement

A.M.T., R.G.M., M.C.R., L.L., and C.L.M. are inventors on a pending patent application for the novel CARs described in this manuscript. R.G.M., C.L.M., and L.L. are co-founders of and hold equity in Syncopation Life Sciences. R.G.M. and C.L.M. are cofounders of and hold equity in Link Cell Therapies. C.L.M. is a cofounder of and holds equity in Lyell Immunopharma. R.G.M, L.L., and E.W.W. are consultants for and hold equity in Lyell Immunopharma. A.M.T. is a consultant for Syncopation Life Sciences. S.R. is a former employee of and holds equity in Lyell Immunopharma. R.G.M. is a consultant for NKarta, Arovella Pharmaceuticals, Illumina Radiopharmaceuticals, GammaDelta Therapeutics, Aptorum Group, and Zai Labs. A.M.T. is a consultant for Syncopation Life Sciences. E.W.W. is a consultant for and holds equity in VISTAN Health.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 17, 2022.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control
Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh, Lea Wenting Rysavy, Skyler P. Rietberg, Eva L. de la Serna, Guillermo Nicolas Dalton, Dorota Klysz, Evan W. Weber, Won-Ju Kim, Peng Xu, Elena Sotillo, Alexander R. Dunn, Crystal L. Mackall, Robbie G. Majzner
bioRxiv 2022.06.17.496457; doi: https://doi.org/10.1101/2022.06.17.496457
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control
Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh, Lea Wenting Rysavy, Skyler P. Rietberg, Eva L. de la Serna, Guillermo Nicolas Dalton, Dorota Klysz, Evan W. Weber, Won-Ju Kim, Peng Xu, Elena Sotillo, Alexander R. Dunn, Crystal L. Mackall, Robbie G. Majzner
bioRxiv 2022.06.17.496457; doi: https://doi.org/10.1101/2022.06.17.496457

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Synthetic Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3586)
  • Biochemistry (7544)
  • Bioengineering (5495)
  • Bioinformatics (20729)
  • Biophysics (10294)
  • Cancer Biology (7950)
  • Cell Biology (11609)
  • Clinical Trials (138)
  • Developmental Biology (6586)
  • Ecology (10166)
  • Epidemiology (2065)
  • Evolutionary Biology (13578)
  • Genetics (9519)
  • Genomics (12816)
  • Immunology (7905)
  • Microbiology (19503)
  • Molecular Biology (7640)
  • Neuroscience (41980)
  • Paleontology (307)
  • Pathology (1254)
  • Pharmacology and Toxicology (2192)
  • Physiology (3259)
  • Plant Biology (7018)
  • Scientific Communication and Education (1293)
  • Synthetic Biology (1947)
  • Systems Biology (5418)
  • Zoology (1113)